Pfizer Inc.
PFE | NYSE
$27.74
+$0.08 (+0.29%)
At close: Sep 21, 2026, 4:02 PM ET
$27.72
-$0.02 (-0.07%)
Pre-market:
Sep 22, 2026, 6:35 AM ET
TTM Period Ending | Q2 2026 Jun 27, 2026 | Q1 2026 Mar 28, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 27, 2025 | Q2 2025 Jun 28, 2025 | Q1 2025 Mar 29, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 28, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jul 1, 2023 | Q1 2023 Apr 1, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Oct 1, 2022 | Q2 2022 Jul 2, 2022 | Q1 2022 Apr 2, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Oct 2, 2021 | Q2 2021 Jul 3, 2021 | Q1 2021 Apr 3, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 63.7B | 63.32B | 62.58B | 62.79B | 63.83B | 62.46B | 63.63B | 60.43B | 56.22B | 55.95B | 59.55B | 69.27B | 78.42B | 93.16B | 100.33B | 99.88B | 101.28B | 92.43B | 81.29B | 69.08B | 55.33B | 46.29B |
Cost of Revenue | 18.27B | 19.41B | 18.57B | 18.09B | 20.85B | 20.65B | 21.15B | 24.94B | 28.61B | 28.17B | 29.74B | 32.05B | 28.43B | 32.91B | 37.75B | 37.53B | 41.4B | 40.18B | 34.38B | 27.39B | 19.39B | 14.23B |
Gross Profit | 45.43B | 43.91B | 44.01B | 44.7B | 42.99B | 41.81B | 42.48B | 35.49B | 27.61B | 27.78B | 29.82B | 37.23B | 49.99B | 60.25B | 62.58B | 62.35B | 59.88B | 52.26B | 46.91B | 41.7B | 35.94B | 32.06B |
Operating Income | 15.98B | 14.85B | 15.44B | 17.47B | 18.89B | 17.2B | 17.13B | 10.14B | 2.17B | 2.64B | 4.77B | 11.38B | 24.08B | 34.68B | 38.04B | 35.97B | 34.02B | 27.06B | 21.83B | 19.47B | 14.22B | 10.74B |
Interest Income | 532M | 575M | 603M | 607M | 585M | 559M | 545M | 984M | 1.39B | 1.58B | 1.63B | 1.15B | 700M | 414M | 251M | 128M | 68M | 51M | 37M | 27M | 32M | 38M |
Pretax Income | 4.21B | 7.91B | 7.52B | 9.15B | 10.53B | 7.39B | 8.02B | 3.9B | -4.16B | -1.79B | 1.06B | 10.42B | 22.77B | 31.95B | 34.73B | 33.33B | 32.17B | 27.67B | 24.31B | 21.04B | 13.77B | 9.84B |
Net Income | 4.34B | 7.49B | 7.77B | 9.82B | 10.75B | 7.87B | 8.02B | 4.27B | -2.59B | -288M | 2.13B | 10.47B | 21.49B | 29.04B | 31.37B | 29.77B | 29.3B | 25.22B | 22.23B | 19.68B | 12.99B | 10.68B |
Selling & General & Admin | 13.29B | 13.28B | 13.35B | 13.84B | 13.89B | 14.18B | 14.61B | 14.86B | 14.83B | 14.57B | 14.47B | 14.43B | 14.47B | 13.95B | 13.11B | 12.65B | 12.15B | 12.06B | 12.25B | 11.96B | 11.83B | 11.6B |
Research & Development | 12.79B | 12.42B | 11.98B | 11.58B | 10.2B | 10.44B | 10.74B | 10.49B | 10.61B | 10.56B | 10.58B | 11.42B | 11.43B | 11.62B | 11.43B | 13.73B | 13.71B | 13.14B | 12.83B | 10.27B | 9.88B | 9.72B |
Other Expenses | 3.37B | 3.36B | 3.26B | 1.81B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 29.45B | 29.06B | 28.58B | 27.22B | 24.09B | 24.61B | 25.35B | 25.35B | 25.44B | 25.14B | 25.05B | 25.85B | 25.9B | 25.57B | 24.54B | 26.38B | 25.86B | 25.2B | 25.08B | 22.23B | 21.72B | 21.32B |
Interest Expense | 2.7B | 2.69B | 2.67B | 2.7B | 2.83B | 2.95B | 3.09B | 3.04B | 2.95B | 2.68B | 2.21B | 1.83B | 1.45B | 1.24B | 1.24B | 1.24B | 1.26B | 1.28B | 1.29B | 1.32B | 1.34B | 1.4B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.72B | 48.47B | 47.14B | 45.31B | 44.94B | 45.27B | 46.5B | 50.29B | 54.05B | 53.31B | 54.79B | 57.9B | 54.34B | 58.48B | 62.29B | 63.91B | 67.26B | 65.37B | 59.46B | 49.61B | 41.11B | 35.55B |
Income Tax Expense | -164M | 384M | -266M | -685M | -235M | -510M | -28M | -401M | -1.6B | -1.54B | -1.11B | -90M | 1.23B | 2.87B | 3.33B | 3.35B | 2.66B | 2.22B | 1.85B | 1.52B | 1.5B | 803M |
Shares Outstanding (Basic) | 5.7B | 5.69B | 5.68B | 5.69B | 5.69B | 5.68B | 5.67B | 5.67B | 5.67B | 5.66B | 5.65B | 5.65B | 5.65B | 5.63B | 5.62B | 5.61B | 5.59B | 5.62B | 5.62B | 5.61B | 5.6B | 5.58B |
Shares Outstanding (Diluted) | 5.7B | 5.73B | 5.69B | 5.71B | 5.71B | 5.71B | 5.7B | 5.71B | 5.7B | 5.7B | 5.65B | 5.65B | 5.71B | 5.73B | 5.74B | 5.72B | 5.71B | 5.76B | 5.77B | 5.73B | 5.68B | 5.66B |
EPS (Basic) | 0.76 | 1.31 | 1.36 | 1.73 | 1.89 | 1.39 | 1.42 | 0.75 | -0.46 | -0.06 | 0.38 | 1.86 | 3.82 | 5.18 | 5.59 | 5.31 | 5.23 | 4.50 | 3.97 | 3.52 | 2.33 | 1.92 |
EPS (Diluted) | 0.76 | 1.31 | 1.36 | 1.72 | 1.89 | 1.38 | 1.41 | 0.74 | -0.47 | -0.07 | 0.35 | 1.82 | 3.75 | 5.07 | 5.47 | 5.19 | 5.11 | 4.40 | 3.90 | 3.46 | 2.29 | 1.89 |
EBITDA | 12.62B | 16.75B | 16.78B | 21.17B | 22.78B | 19.86B | 20.75B | 13.84B | 5.49B | 7.43B | 9.56B | 18.39B | 29.99B | 38.55B | 41.03B | 39.39B | 38.4B | 34.06B | 30.74B | 27.32B | 19.94B | 15.96B |
EBIT | 6.91B | 10.59B | 10.19B | 14.47B | 15.99B | 12.96B | 13.74B | 6.94B | -1.21B | 893M | 3.27B | 12.26B | 24.22B | 33.19B | 35.97B | 34.57B | 33.42B | 28.95B | 25.6B | 22.36B | 15.11B | 11.24B |
Depreciation & Amortization | 5.72B | 6.16B | 6.59B | 6.7B | 6.79B | 6.9B | 7.01B | 6.89B | 6.7B | 6.54B | 6.29B | 6.14B | 5.76B | 5.36B | 5.06B | 4.82B | 4.98B | 5.11B | 5.13B | 4.96B | 4.83B | 4.72B |
Add to Watchlist
Select watchlists to add or remove PFE